FKD Therapies Oy Report issue

For profit Phase 1 Phase 3
Founded: Kuopio Finland (2011)
Status: Defunct (2021)

Organization Overview

First Clinical Trial
2011
NCT01162785
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Alternative names

FKD Therapies Oy of Finland

Active Ingredients

Drugs in Phase 3 Trials (1)

levobupivacaine (chirocaine) (2 trials)

Drugs in Phase 1 Trials (1)

sch 721015 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Urinary Bladder Neoplasms (Phase 3)

Overview

  • Highest Phase: Phase 3
  • # of Trials: 3
  • # of Trial APIs: 2